ST6GAL1 and chronic obstructive pulmonary disease: Furthermore, the level of circulatory ST6GAL1 negatively correlates with the severity of acute airway inflammation, and the administration of recombinant ST6GAL1 to a murine model mimicking acute exacerbations of COPD can alleviate the inflammation symptoms (58).